Annual Total Debt
$35.56 M
+$24.60 M+224.47%
30 September 2023
Summary:
Outlook Therapeutics annual total debt is currently $35.56 million, with the most recent change of +$24.60 million (+224.47%) on 30 September 2023. During the last 3 years, it has risen by +$23.65 million (+198.72%). OTLK annual total debt is now at all-time high.OTLK Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$32.72 M
-$12.02 M-26.87%
30 June 2024
Summary:
Outlook Therapeutics quarterly total debt is currently $32.72 million, with the most recent change of -$12.02 million (-26.87%) on 30 June 2024. Over the past year, it has dropped by -$2.83 million (-7.96%). OTLK quarterly total debt is now -26.87% below its all-time high of $44.74 million, reached on 31 March 2024.OTLK Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OTLK Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -8.0% |
| 3 y3 years | +198.7% | +174.9% |
| 5 y5 years | +137.9% | +119.0% |
OTLK Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +224.5% | -26.9% | +211.1% |
| 5 y | 5 years | at high | +304.1% | -26.9% | +271.9% |
| alltime | all time | at high | +307.2% | -26.9% |
Outlook Therapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $32.72 M(-26.9%) |
| Mar 2024 | - | $44.74 M(+22.4%) |
| Dec 2023 | - | $36.55 M(+2.8%) |
| Sept 2023 | $35.56 M(+224.5%) | $35.56 M(+2.3%) |
| June 2023 | - | $34.74 M(+9.1%) |
| Mar 2023 | - | $31.84 M(-0.0%) |
| Dec 2022 | - | $31.85 M(+190.6%) |
| Sept 2022 | $10.96 M(-7.9%) | $10.96 M(+4.2%) |
| June 2022 | - | $10.52 M(-54.0%) |
| Mar 2022 | - | $22.86 M(+2.0%) |
| Dec 2021 | - | $22.42 M(+88.3%) |
| Sept 2021 | $11.90 M(+35.3%) | $11.90 M(+1.9%) |
| June 2021 | - | $11.68 M(+2.7%) |
| Mar 2021 | - | $11.37 M(+0.7%) |
| Dec 2020 | - | $11.29 M(+28.3%) |
| Sept 2020 | $8.80 M(-41.1%) | $8.80 M(-0.6%) |
| June 2020 | - | $8.85 M(-52.1%) |
| Mar 2020 | - | $18.48 M(+26.6%) |
| Dec 2019 | - | $14.59 M(-2.4%) |
| Sept 2019 | $14.95 M | $14.95 M(-0.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2019 | - | $14.98 M(-8.5%) |
| Mar 2019 | - | $16.37 M(-8.7%) |
| Dec 2018 | - | $17.93 M(-18.2%) |
| Sept 2018 | $21.93 M(+19.1%) | $21.93 M(+0.4%) |
| June 2018 | - | $21.85 M(+0.6%) |
| Mar 2018 | - | $21.72 M(+26.1%) |
| Dec 2017 | - | $17.22 M(-6.5%) |
| Sept 2017 | $18.42 M(+110.9%) | $18.42 M(+8.4%) |
| June 2017 | - | $16.99 M(+37.4%) |
| Mar 2017 | - | $12.36 M(+12.6%) |
| Dec 2016 | - | $10.98 M(+25.7%) |
| Sept 2016 | $8.73 M(-60.2%) | $8.73 M(-5.5%) |
| June 2016 | - | $9.24 M(-37.1%) |
| Mar 2016 | - | $14.68 M(-5.2%) |
| Dec 2015 | - | $15.49 M(-29.5%) |
| Sept 2015 | $21.96 M(0.0%) | $21.96 M(>+9900.0%) |
| June 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | - | $0.00 |
| Sept 2014 | $21.96 M | - |
FAQ
- What is Outlook Therapeutics annual total debt?
- What is the all time high annual total debt for Outlook Therapeutics?
- What is Outlook Therapeutics quarterly total debt?
- What is the all time high quarterly total debt for Outlook Therapeutics?
- What is Outlook Therapeutics quarterly total debt year-on-year change?
What is Outlook Therapeutics annual total debt?
The current annual total debt of OTLK is $35.56 M
What is the all time high annual total debt for Outlook Therapeutics?
Outlook Therapeutics all-time high annual total debt is $35.56 M
What is Outlook Therapeutics quarterly total debt?
The current quarterly total debt of OTLK is $32.72 M
What is the all time high quarterly total debt for Outlook Therapeutics?
Outlook Therapeutics all-time high quarterly total debt is $44.74 M
What is Outlook Therapeutics quarterly total debt year-on-year change?
Over the past year, OTLK quarterly total debt has changed by -$2.83 M (-7.96%)